Axios @axios
The FDA said that it's allowing for the release of two batches of the Johnson & Johnson COVID-19 vaccine made at the Emergent BioSolutions facility in Baltimore, where 100 million doses had been set aside for review after an accidental contamination. https://t.co/39rZu0DXEc — PolitiTweet.org